What changes we may expect in 2010 hypertension diagnosis and management: Insights from the european update document

Giuseppe Mancia, Guido Grassi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

In 2009, the European Society of Hypertension (ESH) has developed a document updating the recommendations for the diagnosis and treatment of hypertension issued in 2007. The main elements of novelty refer to the assessment of organ damage, the blood pressure thresholds for treatment initiation as well as the blood pressure goals, the use of drug combination treatment and the therapeutic intervention in specific clinical conditions. This paper will review the novelties of the ESH update document and the implications of the "new guidelines" for current clinical practice.

Original languageEnglish
Pages (from-to)788-791
Number of pages4
JournalCurrent Vascular Pharmacology
Volume8
Issue number6
Publication statusPublished - Nov 2010

Fingerprint

Blood Pressure
Hypertension
Drug Combinations
Guidelines
Therapeutics

Keywords

  • Antihypertensive treatment
  • Blood pressure
  • Clinical trials
  • Control
  • Guidelines

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pharmacology

Cite this

What changes we may expect in 2010 hypertension diagnosis and management : Insights from the european update document. / Mancia, Giuseppe; Grassi, Guido.

In: Current Vascular Pharmacology, Vol. 8, No. 6, 11.2010, p. 788-791.

Research output: Contribution to journalArticle

@article{2e78e6d8b2f243358dda464c7d3264c1,
title = "What changes we may expect in 2010 hypertension diagnosis and management: Insights from the european update document",
abstract = "In 2009, the European Society of Hypertension (ESH) has developed a document updating the recommendations for the diagnosis and treatment of hypertension issued in 2007. The main elements of novelty refer to the assessment of organ damage, the blood pressure thresholds for treatment initiation as well as the blood pressure goals, the use of drug combination treatment and the therapeutic intervention in specific clinical conditions. This paper will review the novelties of the ESH update document and the implications of the {"}new guidelines{"} for current clinical practice.",
keywords = "Antihypertensive treatment, Blood pressure, Clinical trials, Control, Guidelines",
author = "Giuseppe Mancia and Guido Grassi",
year = "2010",
month = "11",
language = "English",
volume = "8",
pages = "788--791",
journal = "Current Vascular Pharmacology",
issn = "1570-1611",
publisher = "Bentham Science Publishers B.V.",
number = "6",

}

TY - JOUR

T1 - What changes we may expect in 2010 hypertension diagnosis and management

T2 - Insights from the european update document

AU - Mancia, Giuseppe

AU - Grassi, Guido

PY - 2010/11

Y1 - 2010/11

N2 - In 2009, the European Society of Hypertension (ESH) has developed a document updating the recommendations for the diagnosis and treatment of hypertension issued in 2007. The main elements of novelty refer to the assessment of organ damage, the blood pressure thresholds for treatment initiation as well as the blood pressure goals, the use of drug combination treatment and the therapeutic intervention in specific clinical conditions. This paper will review the novelties of the ESH update document and the implications of the "new guidelines" for current clinical practice.

AB - In 2009, the European Society of Hypertension (ESH) has developed a document updating the recommendations for the diagnosis and treatment of hypertension issued in 2007. The main elements of novelty refer to the assessment of organ damage, the blood pressure thresholds for treatment initiation as well as the blood pressure goals, the use of drug combination treatment and the therapeutic intervention in specific clinical conditions. This paper will review the novelties of the ESH update document and the implications of the "new guidelines" for current clinical practice.

KW - Antihypertensive treatment

KW - Blood pressure

KW - Clinical trials

KW - Control

KW - Guidelines

UR - http://www.scopus.com/inward/record.url?scp=78649372906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649372906&partnerID=8YFLogxK

M3 - Article

C2 - 20626339

AN - SCOPUS:78649372906

VL - 8

SP - 788

EP - 791

JO - Current Vascular Pharmacology

JF - Current Vascular Pharmacology

SN - 1570-1611

IS - 6

ER -